• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊癌发生中的遗传因素与微小RNA:潜在的临床靶点

Genetic Factors and MicroRNAs in the Development of Gallbladder Cancer: The Prospective Clinical Targets.

作者信息

Quraishi Roshni, Sanyal Somali, Dwivedi Medha, Moitra Monika, Dwivedi Manish

机构信息

Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Gomtinagar Extension, Lucknow-226028, India.

Research Cell, Amity University Uttar Pradesh, Lucknow Campus, Gomtinagar Extension, Lucknow-226028, India.

出版信息

Curr Drug Targets. 2024;25(6):375-387. doi: 10.2174/0113894501182288240319074330.

DOI:10.2174/0113894501182288240319074330
PMID:38544392
Abstract

Gallbladder cancer (GBC) is an uncommon condition in which malignant (cancer) cells are detected in gallbladder tissue. Cancer is often triggered when normal cells turn malignant and begin to spread. Cancer can also be caused by genetic anomalies that result in uncontrolled cell proliferation and tumor development. MicroRNAs (also known as miRNAs or miRs) are a group of small, endogenous, non-coding RNAs of 19-23 nucleotides in length, which play a key role in post-transcriptional gene regulation. These miRNAs serve as negative gene regulators by supervising target genes and regulating biological processes, including cell proliferation, migration, invasion, and apoptosis. Cancer development and progression relate to aberrant miRNA expression. This review demonstrated the implication of various genetic factors and microRNAs in developing and regulating GBC. This suggests the potential of genes and RNAs as the diagnostic, prognostic, and therapeutic targets in gallbladder cancer.

摘要

胆囊癌(GBC)是一种罕见病症,其中在胆囊组织中检测到恶性(癌)细胞。癌症通常在正常细胞转变为恶性并开始扩散时引发。癌症也可能由导致细胞不受控制地增殖和肿瘤发展的基因异常引起。微小RNA(也称为miRNA或miR)是一组长度为19 - 23个核苷酸的小的内源性非编码RNA,其在转录后基因调控中起关键作用。这些微小RNA通过监督靶基因并调节包括细胞增殖、迁移、侵袭和凋亡在内的生物学过程,作为负性基因调节因子发挥作用。癌症的发生和发展与异常的微小RNA表达有关。本综述阐述了各种遗传因素和微小RNA在胆囊癌发生和调控中的作用。这表明基因和RNA作为胆囊癌诊断、预后和治疗靶点的潜力。

相似文献

1
Genetic Factors and MicroRNAs in the Development of Gallbladder Cancer: The Prospective Clinical Targets.胆囊癌发生中的遗传因素与微小RNA:潜在的临床靶点
Curr Drug Targets. 2024;25(6):375-387. doi: 10.2174/0113894501182288240319074330.
2
MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer.微小RNA表达及其在胆囊癌诊断和治疗中的意义。
Oncotarget. 2015 Jun 10;6(16):13914-21. doi: 10.18632/oncotarget.4227.
3
MicroRNA aberrations: An emerging field for gallbladder cancer management.微小RNA异常:胆囊癌治疗的一个新兴领域。
World J Gastroenterol. 2016 Feb 7;22(5):1787-99. doi: 10.3748/wjg.v22.i5.1787.
4
Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.微小 RNA-205-5p 的过表达通过下调 PRKCE 对胆囊癌细胞干细胞耐药性发挥抑制作用。
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20194509.
5
Non-coding RNAs as potential biomarkers of gallbladder cancer.非编码 RNA 作为胆囊癌的潜在生物标志物。
Clin Transl Oncol. 2023 Jun;25(6):1489-1511. doi: 10.1007/s12094-022-03056-7. Epub 2022 Dec 28.
6
LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.LncRNA-HGBC 被 HuR 稳定后通过调节 miR-502-3p/SET/AKT 轴促进胆囊癌进展。
Mol Cancer. 2019 Nov 21;18(1):167. doi: 10.1186/s12943-019-1097-9.
7
MicroRNA signatures in total peripheral blood of gallbladder cancer patients.胆囊癌患者外周血中的微小RNA特征
Tumour Biol. 2015 Sep;36(9):6985-90. doi: 10.1007/s13277-015-3412-4. Epub 2015 Apr 11.
8
The potential role of miRNAs in the pathogenesis of gallbladder cancer - A focus on signaling pathways interplay.微小RNA在胆囊癌发病机制中的潜在作用——聚焦信号通路的相互作用
Pathol Res Pract. 2023 Aug;248:154682. doi: 10.1016/j.prp.2023.154682. Epub 2023 Jul 10.
9
Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.长链非编码RNA TUG1通过负向调控miR-300促进胆囊癌细胞增殖和转移。
Biomed Pharmacother. 2017 Apr;88:863-869. doi: 10.1016/j.biopha.2017.01.150. Epub 2017 Feb 6.
10
miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance.微小RNA对胆囊癌的调控——特别关注诊断、进展和耐药性
Pathol Res Pract. 2023 Aug;248:154684. doi: 10.1016/j.prp.2023.154684. Epub 2023 Jul 13.

本文引用的文献

1
Anthelmintic Drugs as Emerging Immune Modulators in Cancer.抗蠕虫药物作为癌症治疗中的新兴免疫调节剂
Int J Mol Sci. 2023 Mar 29;24(7):6446. doi: 10.3390/ijms24076446.
2
Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis.山奈酚通过抑制 PKM2 介导的糖酵解逆转结直肠癌细胞对 5-Fu 的耐药性。
Int J Mol Sci. 2022 Mar 24;23(7):3544. doi: 10.3390/ijms23073544.
3
miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression.miR-182 靶向重编程肿瘤相关巨噬细胞并限制乳腺癌进展。
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6). doi: 10.1073/pnas.2114006119.
4
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1.Keap1 突变使肺腺癌依赖于 Slc33a1。
Nat Cancer. 2020 Jun;1(6):589-602. doi: 10.1038/s43018-020-0071-1. Epub 2020 Jun 8.
5
Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer.细胞黏附分子CADM1在癌症中的功能及临床特征
Front Cell Dev Biol. 2021 Jul 30;9:714298. doi: 10.3389/fcell.2021.714298. eCollection 2021.
6
Clinical epidemiology of gallbladder cancer in North-Central India and association of immunological markers, NLR, MLR and PLR in the diagnostic/prognostic prediction of GBC.印度中北部胆囊癌的临床流行病学及免疫标志物、NLR、MLR 和 PLR 在 GBC 诊断/预后预测中的相关性。
Cancer Treat Res Commun. 2021;28:100431. doi: 10.1016/j.ctarc.2021.100431. Epub 2021 Jul 14.
7
MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1.miR-130a 在皮肤鳞状细胞癌中作为肿瘤抑制 microRNA,通过抑制 ACVR1 来调节 BMP/SMAD 通路的活性。
J Invest Dermatol. 2021 Aug;141(8):1922-1931. doi: 10.1016/j.jid.2021.01.028. Epub 2021 Mar 22.
8
Current perspectives on inhibitory SMAD7 in health and disease.当前对健康和疾病中抑制性 SMAD7 的观点。
Crit Rev Biochem Mol Biol. 2020 Dec;55(6):691-715. doi: 10.1080/10409238.2020.1828260. Epub 2020 Oct 20.
9
Exon 15 Mutations in Papillary Carcinoma and Adjacent Thyroid Parenchyma: A Search for the Early Molecular Events Associated with Tumor Development.乳头状癌及相邻甲状腺实质中的第15外显子突变:探寻与肿瘤发生相关的早期分子事件
Cancers (Basel). 2020 Feb 12;12(2):430. doi: 10.3390/cancers12020430.
10
Mutations in exon 8 of are associated with shorter survival in patients with advanced lung cancer.[基因名称]第8外显子的突变与晚期肺癌患者较短的生存期相关。
Oncol Lett. 2019 Sep;18(3):3159-3169. doi: 10.3892/ol.2019.10625. Epub 2019 Jul 16.